Lung cancer

Case for targeted lung cancer screening bolstered by NELSON results, experts say

The case for targeted screening programs for lung cancer has been bolstered by results from the European NELSON study, a leading UK clinician argues. Professor David Baldwin, consultant respiratory physician in Nottingham and a member of NHS England’s advisory group on lung cancer, said the long-awaited results from the NELSON study meant there would likely ...

Already a member?

Login to keep reading.

© 2021 the limbic